Patents by Inventor Wencui MA

Wencui MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANTI-CD4 ANTIBODIES
    Publication number: 20220324976
    Abstract: The present disclosure provides herein anti-CD4 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.
    Type: Application
    Filed: January 12, 2022
    Publication date: October 13, 2022
    Inventors: Ziyong SUN, Wencui MA, Hongli MA, Qian (Nicole) NIU, Ying JIN, Wen YU, Huanhuan ZHANG, Chengcheng WANG, Yangzhou WANG, Jean Pierre WERY
  • Anti-CD4 antibodies
    Patent number: 11254745
    Abstract: The present disclosure provides herein anti-CD4 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.
    Type: Grant
    Filed: May 9, 2021
    Date of Patent: February 22, 2022
    Assignee: CROWN BIOSCIENCE INC.
    Inventors: Ziyong Sun, Wencui Ma, Hongli Ma, Qian (Nicole) Niu, Ying Jin, Wen Yu, Huanhuan Zhang, Chengcheng Wang, Yangzhou Wang, Jean Pierre Wery
  • Anti-CTLA4 antibodies
    Patent number: 10618962
    Abstract: The present disclosure provides antibodies and antigen binding fragments against CTLA4, which can block the binding of CTLA4 to its ligand. The antibodies of disclosure provide agents for treating diseases, such as cancer.
    Type: Grant
    Filed: October 10, 2016
    Date of Patent: April 14, 2020
    Assignee: CROWN BIOSCIENCE (TAICANG) INC.
    Inventors: Ziyong Sun, Man Zhou, Wencui Ma, Hongli Ma, Wei Chen
  • NOVEL ANTI-CTLA4 ANTIBODIES
    Publication number: 20190225690
    Abstract: The present disclosure provides antibodies and antigen binding fragments against CTLA4, which can block the binding of CTLA4 to its ligand. The antibodies of disclosure provide agents for treating diseases, such as cancer.
    Type: Application
    Filed: October 10, 2016
    Publication date: July 25, 2019
    Inventors: Ziyong SUN, Man ZHOU, Wencui MA, Hongli MA, Wei CHEN